Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.8 USD | +1.26% | -1.83% | +15.77% |
May. 14 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
May. 06 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.77% | 6.6B | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Wells Fargo Adjusts Price Target on Blueprint Medicines to $48 From $47, Keeps Equalweight Rating